BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20453658)

  • 1. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
    Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
    Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
    Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
    Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Int Clin Psychopharmacol; 2016 Jan; 31(1):1-7. PubMed ID: 26544898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
    World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-HT1A gene polymorphisms contributed to antidepressant response in major depression].
    Kato M; Fukuda T; Wakeno M; Okugawa G; Takekita Y; Serretti A; Azuma J; Kinoshita T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Feb; 29(1):23-31. PubMed ID: 19326813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatization in major depression--clinical features and genetic associations.
    Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
    Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome.
    Murata Y; Kobayashi D; Imuta N; Haraguchi K; Ieiri I; Nishimura R; Koyama S; Mine K
    J Clin Psychopharmacol; 2010 Feb; 30(1):11-7. PubMed ID: 20075642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.
    Basu A; Chadda RK; Sood M; Kaur H; Kukreti R
    Indian J Med Res; 2015 Jul; 142(1):40-5. PubMed ID: 26261165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
    Yoon HK; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between serotonin-related gene polymorphisms and panic disorder.
    Yoon HK; Yang JC; Lee HJ; Kim YK
    J Anxiety Disord; 2008 Dec; 22(8):1529-34. PubMed ID: 18436425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonergic gene polymorphisms (5-HTTLPR, 5HTR1A, 5HTR2A), and population differences in aggression: traditional (Hadza and Datoga) and industrial (Russians) populations compared.
    Butovskaya ML; Butovskaya PR; Vasilyev VA; Sukhodolskaya JM; Fekhredtinova DI; Karelin DV; Fedenok JN; Mabulla AZP; Ryskov AP; Lazebny OE
    J Physiol Anthropol; 2018 Apr; 37(1):10. PubMed ID: 29661255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.